Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoroscopic MR assessment of focal liver lesions with Primovist
2008-004991-28Phase 4Completed
- Sponsor
- Medical Faculty Magdeburg
- Start
- Feb 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gadoxetate disodium in focal liver lesion, sponsored by Medical Faculty Magdeburg. Primary endpoint: Primary image quality comparison. Started Feb 2009; status: completed.
02
Drugs
gadoxetate disodium
03
Conditions
focal liver lesion
Beyond the preview
Go deeper on 2008-004991-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004991-28.